| Income Statement |
| Total Revenue | 170.90M |
|
| Revenues (USD) | 170.90M |
| Cost of Revenue | 53.27M |
| Gross Profit | 117.63M |
| Operating Expenses | 91.56M |
| Research and Development Expense | 50.84M |
| Selling, General and Administrative Expense | 40.10M |
| Operating Income | 26.07M |
| Interest Expense | -1.27M |
| Income Tax Expense | 5.45M |
| Net Income | 21.82M |
| Net Income Common Stock | 21.82M |
| Net Income Common Stock (USD) | 21.82M |
| Consolidated Income | 21.82M |
| Earnings per Basic Share | 0.16 |
| Earnings per Basic Share (USD) | 0.16 |
| Earnings per Diluted Share | 0.16 |
| Earning Before Interest & Taxes (EBIT) | 26.00M |
| Earning Before Interest & Taxes (USD) | 26.00M |
| Weighted Average Shares | 136.81M |
| Weighted Average Shares Diluted | 139.39M |
| Balance Sheet |
| Cash and Equivalents | 139.96M |
| Cash and Equivalents (USD) | 139.96M |
| Trade and Non-Trade Receivables | 118.11M |
| Current Assets | 386.23M |
| Property, Plant & Equipment Net | 115.05M |
| Total Assets | 898.98M |
| Total Debt | 34.06M |
| Current Liabilities | 110.96M |
| Debt Non-Current | 34.06M |
| Total Liabilities | 158.82M |
| Accumulated Retained Earnings (Deficit) | 234.00M |
| Accumulated Other Comprehensive Income | -3.92M |
| Shareholders Equity | 740.16M |
| Shareholders Equity (USD) | 740.16M |
| Assets Non-Current | 512.75M |
| Total Debt (USD) | 34.06M |
| Goodwill and Intangible Assets | 318.93M |
| Inventory | 88.23M |
| Liabilities Non-Current | 47.86M |
| Trade and Non-Trade Payables | 58.76M |
| Tax Assets | 59.42M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 11.22M |
| Net Cash Flow from Financing | -28.78M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.07M |
| Capital Expenditure | -15.42M |
| Issuance (Purchase) of Equity Shares | -15.00M |
| Net Cash Flow from Investing | -15.42M |
| Net Cash Flow from Operations | 50.26M |
| Effect of Exchange Rate Changes on Cash | 15.00K |
| Share Based Compensation | 28.07M |